Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOUNCE THERAPEUTICS, INC.

(JNCE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

JOUNCE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

06/23/2021 | 04:44pm EDT

Item 5.07. Submission of Matters to a Vote of Security Holders.


Jounce Therapeutics, Inc. (the "Company") held its Annual Meeting of
Stockholders on June 18, 2021. The following is a summary of the matters voted
on at that meeting.
(a) The stockholders of the Company elected J. Duncan Higgons, Robert Iannone,
M.D., M.S.C.E. and Luisa Salter-Cid, Ph.D. as Class I directors, each for a
three-year term ending at the annual meeting of stockholders to be held in 2024
and until his or her successor has been duly elected and qualified. The results
of the stockholders' vote with respect to the election of the Class I directors
were as follows:
Name                                 Votes For       Votes Withheld        Broker Non-Votes
J. Duncan Higgons                    31,777,408        10,873,423             4,163,492
Robert Iannone, M.D., M.S.C.E.       30,977,227        11,673,604             4,163,492
Luisa Salter-Cid, Ph.D.              42,584,638          66,193               4,163,492


(b) The stockholders of the Company ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the stockholders' vote with respect to such ratification were as follows:

     For            Against        Abstain        Broker Non-Votes
  41,124,791        38,600         16,355                -


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about JOUNCE THERAPEUTICS, INC.
09/15JOUNCE THERAPEUTICS : Departures of Directors or Certain Officers; Election of Directors; ..
PU
09/15JOUNCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/15Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
GL
09/15Jounce Therapeutics, Inc. Announces Board Changes
CI
09/15NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
09/14JOUNCE THERAPEUTICS : Raymond James Upgrades Jounce Therapeutics to Outperform From Market..
MT
09/02Jounce Therapeutics to Present at Upcoming Investor Conferences in September
GL
08/05JOUNCE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/05Jounce Therapeutics Reports Second Quarter 2021 Financial Results
GL
08/05JOUNCE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial State..
AQ
More news
Analyst Recommendations on JOUNCE THERAPEUTICS, INC.
More recommendations